Felder C C, Albrecht F E, Campbell T, Eisner G M, Jose P A
Section on Pharmacology, National Institute of Mental Health, Bethesda, Maryland 20892.
Am J Physiol. 1993 Jun;264(6 Pt 2):F1032-7. doi: 10.1152/ajprenal.1993.264.6.F1032.
When D1 dopamine agonists are incubated with renal cortical tissue, Na+/H+ exchange activity is inhibited, presumably due to D1 receptor-mediated stimulation of adenylyl cyclase and subsequent increase in protein kinase A activity. Although the role of adenosine 3',5'-cyclic monophosphate (cAMP) and cAMP-dependent protein kinase in the regulation of Na+/H+ exchange activity is well established, receptors functionally coupled to adenylyl cyclase can regulate Na+/H+ exchange activity independently of changes of cAMP accumulation. The current studies were designed to determine whether D1 agonists can inhibit Na+/H+ exchange activity independently of changes of cAMP accumulation and also to determine the role of G proteins in this process. The D1 agonist, fenoldopam, inhibited Na+/H+ exchange activity in a time-related and concentration-dependent manner. The 50% inhibitory concentration was 5-34 microM. Occupation of the renal D1 receptor mediates this action, since the D1 antagonist, SKF 83742, partially blocks the effect. This action, however, was independent of adenylyl cyclase, protein kinase A, and protein kinase C activity. Inhibition of adenylyl cyclase with dideoxyadenosine or inhibition of protein kinase A and C with the isoquinolines N-(2-guanidinoethyl)-5-isoquinolinesulfonamide hydrochloride (H-4) and 1-(5-isoquinolinesfulfonyl)-2-methylpiperazine (H-7) did not block the effect of fenoldopam on the exchanger. The action of fenoldopam is not due to an amiloride-like action on the exchanger, because kinetic analysis of the inhibitory action was noncompetitive and the effect of fenoldopam was time dependent. The process involved G proteins, since guanosine 5'-O-(2-thiodiphosphate) prevented while guanosine 5'-O-(3-thiotriphosphate) increased the inhibitory effect of fenoldopam.
当 D1 多巴胺激动剂与肾皮质组织一起孵育时,Na+/H+交换活性受到抑制,推测这是由于 D1 受体介导的腺苷酸环化酶刺激以及随后蛋白激酶 A 活性增加所致。尽管 3',5'-环磷酸腺苷(cAMP)和 cAMP 依赖性蛋白激酶在调节 Na+/H+交换活性中的作用已得到充分证实,但与腺苷酸环化酶功能偶联的受体可独立于 cAMP 积累的变化来调节 Na+/H+交换活性。当前的研究旨在确定 D1 激动剂是否能够独立于 cAMP 积累的变化来抑制 Na+/H+交换活性,并确定 G 蛋白在此过程中的作用。D1 激动剂非诺多泮以时间相关和浓度依赖性方式抑制 Na+/H+交换活性。50%抑制浓度为 5 - 34 μM。肾 D1 受体的占据介导了这一作用,因为 D1 拮抗剂 SKF 83742 可部分阻断该效应。然而,这一作用独立于腺苷酸环化酶、蛋白激酶 A 和蛋白激酶 C 的活性。用双脱氧腺苷抑制腺苷酸环化酶,或用异喹啉 N-(2-胍基乙基)-5-异喹啉磺酰胺盐酸盐(H-4)和 1-(5-异喹啉磺酰基)-2-甲基哌嗪(H-7)抑制蛋白激酶 A 和 C,均不能阻断非诺多泮对交换体的作用。非诺多泮的作用并非由于其对交换体有类似氨氯地平的作用,因为对抑制作用的动力学分析是非竞争性的,且非诺多泮的作用具有时间依赖性。该过程涉及 G 蛋白,因为 5'-O-(2-硫代二磷酸)鸟苷可阻止而非诺多泮的抑制作用,而 5'-O-(3-硫代三磷酸)鸟苷则增强了非诺多泮的抑制作用。